Table 3b. Comparison at different thresholds between clinical and combined grades.
| Cutoff | κ | Sensitivity | CI | Specificity | CI | LR+ | CI | LR− | CI |
|---|---|---|---|---|---|---|---|---|---|
| Proliferative vs nonprolif | 0.858 | 0.85 | 0.79–0.90 | 0.99 | 0.99–0.99 | 91.11 | 56.51–146.90 | 0.15 | 0.1–0.22 |
| Non-STDR vs sight-threatening DR | 0.746 | 0.75 | 0.72–0.78 | 0.97 | 0.96–0.98 | 24.89 | 17.92–34.58 | 0.25 | 0.23–0.29 |
| CSMO vs no CSMO | 0.623 | 0.78 | 0.72–0.83 | 0.94 | 0.93–0.95 | 13.30 | 10.95–16.15 | 0.23 | 0.18–0.30 |
| Any maculopathy vs no maculopathy | 0.679 | 0.88 | 0.85–0.91 | 0.86 | 0.85–0.88 | 6.45 | 5.67–7.33 | 0.14 | 0.11–0.17 |
Abbreviations: CI, confidence interval; LR+ and LR−, positive and negative likelihood ratios.
N=1964 for retinopathy; N=2110 for maculopathy.